Benjamin P. Saylor

A collaborative effort involving Duke University experts in urology, engineering, pathology, and mathematics has resulted in improved efficiency for shock wave lithotripsy, the researchers report.

Astellas Pharma Inc. and Medivation Inc. have submitted a supplemental new drug application to the FDA seeking approval of enzalutamide (XTANDI) capsules for the treatment of men with metastatic castration-resistant prostate cancer who have not received chemotherapy.

For women undergoing surgery for vaginal prolapse and stress urinary incontinence, neither sacrospinous ligament fixation nor uterosacral ligament vaginal vault suspension was superior to the other for functional or adverse event outcomes, according to a recent study.

A diet typically used to lower blood pressure may reduce the risk of kidney stone development, according to a small, recently published study.

Drugs and devices in the pipeline from Medivation, Astellas Pharma, Teva Pharmaceuticals, Boston Scientific, Northwest Biotherapeutics, and Generex Biotechnology.

New products and services from UroGPO, Caldera Medical, Auxilium Pharmaceuticals, VIVUS, and Jeffrey Albaugh, PhD, APRN.

The latest products and services from Lambert Academic Publishing, the AUA, United Guardian, and SpryPublishing.

Ureteric calculi at a skin-to-stone distance (SSD) of over 13 cm can be successfully managed using extracorporeal shock wave lithotripsy, British researchers report.

The FDA has granted 510(k) clearance for American Medical Systems, Inc.’s RetroArc retropubic sling system for treatment of female stress urinary incontinence.

Ceftolozane/tazobactam, an investigational antibiotic, showed positive top-line results in a pivotal phase III clinical trial of the drug’s use in complicated urinary tract infections, Cubist Pharmaceuticals, Inc. reported.

The latest products and services from Mission Pharmacal, Eli Lilly, Richard Wolf Medical Instruments Corp., and Inspire on Purpose Publishing.

An investigational prostate cancer treatment slows the disease’s progression and may increase survival, especially among men whose cancer has metastasized to the bones, according to a recent analysis.

Older men with midrange testosterone levels tend to live longer compared with men who have low or high levels, Australian researchers say.

GenomeDx Biosciences has entered into contractual agreements for diagnostic laboratory testing as a participating provider that will expand insurance coverage for the company’s Decipher test for prostate cancer.

The use of voided midstream urine cultures in diagnosing cystitis has limited value but can be modified to avoid undertreatment and inappropriate treatment, according to a recently published study.

Among a group of men who underwent coronary angiography and had a low serum testosterone level, the use of testosterone therapy was associated with increased risk of death, heart attack, or ischemic stroke, according to a recent study.

Prostate cancer has made its way into another set of Choosing Wisely recommendations, this time from the American Society of Clinical Oncology.

Men with short-ended chromosomes in the immune cells in their blood appear to be at increased risk for aggressive prostate cancer compared with men with long-ended chromosomes, according to findings from a recent study.

A study of several hundred chemicals used in commercial pesticides has found only weak evidence that any of them are associated with hypospadias, the authors reported.

The FDA has approved a product label addition for the phosphodiesterase-type-5 inhibitor tadalafil (Cialis) that involves its use with finasteride (Proscar).

Vitamin D does not appear to increase risk for developing kidney stones, say researchers from the University of California, San Diego.

Standard and reduced high-dose volume radiation therapy for muscle-invasive bladder cancer provide similar tumor control and decreased late toxicity when compared to surgery, say the authors of a study from the United Kingdom.

The latest products and services from Cook Medical, American Medical Systems, Dialog Medical, Astellas Pharma U.S., Giffen Solutions, the Société Internationale d’Urologie, Merck Consumer Care, and the Bladder Cancer Advocacy Network.

The American Society for Radiation Oncology and the American Academy of Family Physicians have both released recommendations on the diagnosis and treatment of prostate cancer as part of the Choosing Wisely campaign.

The level of expression of three genes associated with aging can be used to predict whether seemingly low-risk prostate cancer will remain slow growing, according to a recent study.

A recent study has shown that in women with moderate-to-severe stress urinary incontinence, surgery is more effective than physiotherapy.

Coffee consumption is associated with a lower risk of prostate cancer recurrence and progression, researchers reported.

The risk of women developing kidney stones is rising, as is the number of cases being seen in U.S. emergency departments, while the rate of hospitalization for the disorder has remained stable, recent study findings indicate.